Home
About
Overview
Sharing Data
ORCID
Help
History (33)
The safety of rosiglitazone in the treatment of type 2 diabetes.
Perceptions of cancer as a death sentence: Tracking trends in public perceptions from 2008 to 2017.
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
Nonhuman primate reagent resource – Supplement
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
See All 33 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Usami Y, Wu Y, G?ttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature. 2015 Oct 08; 526(7572):218-23.
View in:
PubMed
subject areas
CD4-Positive T-Lymphocytes
Cell Line
Down-Regulation
Gene Deletion
Gene Products, gag
HIV Infections
HIV-1
Host-Pathogen Interactions
Humans
Leukemia Virus, Murine
Membrane Glycoproteins
Membrane Proteins
nef Gene Products, Human Immunodeficiency Virus
Neoplasm Proteins
Protein Transport
Receptors, Cell Surface
Virion
Virus Replication
authors with profiles
Yoshiko Usami PhD
Yuanfei Wu MD, PhD